WAYLIVRA Trademark

Trademark Overview

On Thursday, August 25, 2016, a trademark application was filed for WAYLIVRA with the United States Patent and Trademark Office. The USPTO has given the WAYLIVRA trademark a serial number of 87150030. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 24, 2020. This trademark is owned by Akcea Therapeutics, Inc.. The WAYLIVRA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and human therapeutic preparations and agents for treating and preventing lipid diseases and conditions, cardiometabolic diseases and conditions, and pancreatitis; pharmaceutical preparations and human therapeutic preparations and agents for lowering protein apoc3 and triglyceride levels in blood, controlling blood glucose, and reducing abdominal pain and pancreatic inflammation; antisense oligonucleotides; injectable pharmaceuticals for metabolic diseases and conditions
waylivra

General Information

Serial Number87150030
Word MarkWAYLIVRA
Filing DateThursday, August 25, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 24, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2017

Trademark Statements

Goods and Servicespharmaceutical preparations and human therapeutic preparations and agents for treating and preventing lipid diseases and conditions, cardiometabolic diseases and conditions, and pancreatitis; pharmaceutical preparations and human therapeutic preparations and agents for lowering protein apoc3 and triglyceride levels in blood, controlling blood glucose, and reducing abdominal pain and pancreatic inflammation; antisense oligonucleotides; injectable pharmaceuticals for metabolic diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 30, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAkcea Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAkcea Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, August 24, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 24, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 15, 2020EXTENSION 5 GRANTED
Monday, January 13, 2020EXTENSION 5 FILED
Wednesday, January 15, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 13, 2020TEAS EXTENSION RECEIVED
Thursday, January 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 4, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2019EXTENSION 4 GRANTED
Tuesday, July 2, 2019EXTENSION 4 FILED
Tuesday, July 2, 2019TEAS EXTENSION RECEIVED
Tuesday, January 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, January 6, 2019EXTENSION 3 GRANTED
Sunday, January 6, 2019EXTENSION 3 FILED
Sunday, January 6, 2019TEAS EXTENSION RECEIVED
Thursday, July 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 17, 2018EXTENSION 2 GRANTED
Tuesday, July 17, 2018EXTENSION 2 FILED
Tuesday, July 17, 2018TEAS EXTENSION RECEIVED
Thursday, January 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2018EXTENSION 1 GRANTED
Tuesday, January 16, 2018EXTENSION 1 FILED
Tuesday, January 16, 2018TEAS EXTENSION RECEIVED
Tuesday, July 18, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, June 4, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, February 10, 2017EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 8, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, December 8, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 8, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, December 8, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 6, 2016ASSIGNED TO EXAMINER
Tuesday, August 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

waylivra preparations diseases conditions therapeutic human blood pharmaceutical agents pain abdominal